PKM and glioblastoma: By reducing pyruvate kinase M2 (PKM2) via inhibition of the nuclear factor kappa B (NF‐κB) signaling pathway, N6‐isopentenyladenosine (iPA) decreases the Warburg effect in glioblastoma cells, thus impairing cancer cell proliferation.